For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
Related Content:
Understanding Stage 1 Polycythemia Vera: What Every Patient Should Know
How Vaccines Can Partner With Immunotherapy to Treat Lung Cancer
FDA Approves Imfinzi Plus Chemo in GC/GEJC
More Than a Cyst: The Fear Cancer Leaves Behind
